ENDOBESITY II STUDY

BAROnova is currently enrolling patients in the ENDObesity II Study, a twelve-month multicenter US pivotal clinical trial designed to test the safety and effectiveness of the TransPyloric Shuttle.  For more information, please visit www.endobesitystudy.com.